Predicted protein targets (top 2)
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5187737 | 0.75 | MCL1 (0.36) | NQO1 | |
| SCHEMBL9704543 | 0.75 | TDP1 (0.36) | NQO1 | |
| SCHEMBL10405288 | 0.74 | — | — | |
| SCHEMBL25075144 | 0.71 | CHRNB2 (0.33) | CYP3A4 | |
| SCHEMBL13897445 | 0.71 | TSHR (0.40) | NQO1 | |
| SCHEMBL9474699 | 0.71 | NQO1 (0.33) | CYP3A4NQO1 | |
| SCHEMBL19416824 | 0.69 | — | — | |
| SCHEMBL968737 | 0.69 | — | — | |
| SCHEMBL14466277 | 0.68 | — | — | |
| SCHEMBL965496 | 0.68 | CA1 (0.38) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2023010119-A1 | TREATING CANCERS WITH COMBINATIONS OF PARP INHIBITOR AND ACYLFULVENES | LANTERN PHARMA INC. (US) | 2023-02-02 | — | — | WO | disclosed |